September 22, 2026

Michelle Lee, M.D.

Dr. Michelle Hyunju Lee graduated from Wake Forest School of Medicine in Winston-Salem, NC, and received her internal medicine residency training at the University of Maryland Medical Center in Baltimore, MD. She then completed her Hematology and Oncology fellowship at Boston Medical Center where she was elected and served as Chief Fellow. Dr. Lee is […]

September 22, 2026

Rami Komrokji, M.D.

After earning a medical degree in 1996 from the Jordan University School of Medicine, Dr. Rami Komrokji completed an internship and residency at Case Western University, St. Vincent Program.  He then completed a fellowship at Strong Memorial Hospital, University of Rochester, in Hematology/Oncology and Hematopoietic Stem Cell Transplantation. Dr Komrokji is expert in myeloid neoplasms […]

September 22, 2026

Sung-Yong Kim, M.D., Ph.D.

Prof. Kim is Chair of the Korea MPN Working Party and a hematologist specializing in myeloproliferative neoplasms. He currently serves as Professor and Head of the Division of Hematology at Konkuk University Medical Center, as well as Director of the Education and Training Department at Konkuk University Hospital. He received his M.D. (1995) and Ph.D. […]

September 22, 2026

Kenneth Kaushansky, M.D.

Dr. Kenneth Kaushansky is a physician-scientist specializing in hematology and is known internationally for his research on the molecular biology of blood cell production. Dr. Kaushansky has been continuously funded by the National Institutes of Health to perform cutting edge biomedical research for more than 30 years. The goal of the Kaushansky laboratory is to […]

September 22, 2026

Gabriela S Hobbs, M.D.

Dr. Gabriela Hobbs is a hematology-oncology physician who specializes in the care of patients with myeloproliferative neoplasms (MPN), chronic myeloid leukemia and leukemia. She is an active clinical researcher and lead the MPN research program at Massachusetts General Hospital (MGH). She leads several clinical trials and participate in translational research for MPN. In addition, she […]

September 22, 2026

Harry Gill, M.D., Ph.D.

Prof. Gill graduated in 2006 and joined Queen Mary Hospital in 2007. He completed Haematology and Haematological Oncology training in 2014, followed by Haematopathology training from 2017 to 2019. He earned his PhD in 2019, focusing on the genomics of myeloproliferative neoplasms and became the First Fellow in Genetics and Genomics Medicine in 2023. He […]

September 22, 2026

Minghui Duan, M.D.

Dr. Duan is actively involved in professional medical organizations. He serves as a committee member of the Hematopoietic Stem Cell Application Group of the Chinese Medical Association’s Hematology Branch, the vice – chairman of the MPN/MDS Branch of the China Medical Education Association, and a member of the expert committees of several other professional associations.

September 22, 2026

Ghaith Abu-Zeinah, M.D.

Ghaith Abu-Zeinah, MD, is an Assistant Professor in Medicine at Weill Cornell Medical College and an Assistant Attending Physician at the NewYork-Presbyterian Hospital. Dr. Abu-Zeinah earned his M.D. with academic distinction from the Weill Cornell Medical College in Qatar in 2013. He completed his residency training in Internal Medicine (2016) and fellowship training in Hematology/Oncology […]

September 22, 2026

Prithviraj Bose, M.D.

Dr. Prithviraj Bose is a professor and co-leader of the section of myeloproliferative neoplasms (MPNs) within the Department of Leukemia at the MD Anderson Cancer Center in Houston, TX. After obtaining his medical degree from the University of Calcutta in Kolkata, India, where he attended the Calcutta Medical College, Dr. Bose completed an internship in […]